Literature DB >> 14578916

Aggressive blood pressure control in general practice (ABC-GP) study: can the new targets be reached?

G S Stergiou1, A K Karotsis, A Symeonidis, V A Vassilopoulou.   

Abstract

Based on outcome trials, guidelines for hypertension management recommend lower blood pressure (BP) goals using an individualized treatment strategy (IND) and referral to a specialist of patients uncontrolled after 6 months of treatment. This study aimed to evaluate the performance of General Practitioners (GPs) in reaching the recommended BP goals using the IND, or a stepwise treatment strategy (STEP) as used in the outcome trials. Trained GPs were randomized to reach the BP goals within 6 months using the IND or a STEP strategy in untreated or treated uncontrolled hypertensives. In all, 24 GPs recruited 528 patients of whom 443 were analysed (mean age 65+/-9 years, 42% men, 70% treated, STEP/IND 12/12 GPs, 231/211 patients). After 6 months, 83% of the patients had reached the diastolic BP goal, whereas only 51% the systolic (P<0.0001 for difference). Factors associated with uncontrolled systolic BP were diabetes, age >60 years and triple antihypertensive therapy at baseline. A faster BP reduction was achieved during the first 3 months using the STEP strategy, but at the cost of using more drugs (combination therapy in 68/59% for STEP/IND, P=0.06). At 6 months similar rates of control were achieved with the two strategies. In conclusion, in primary care the diastolic BP goal can be reached within 6 months in the majority of patients, whereas systolic BP remains uncontrolled in 50% of the cases. The IND should be the recommended treatment strategy, but further investigation is required on the reasons for treatment failure and the optimal strategy for its improvement.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14578916     DOI: 10.1038/sj.jhh.1001610

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  5 in total

1.  Treating hypertension with guidelines in general practice.

Authors:  Neil C Campbell; Peter Murchie
Journal:  BMJ       Date:  2004-09-04

Review 2.  Combination pharmacotherapy in hypertension.

Authors:  George S Stergiou
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

3.  Effectiveness, safety and cost of drug substitution in hypertension.

Authors:  Atholl Johnston; Panagiotis Stafylas; George S Stergiou
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335

4.  Beyond the Evidence of the New Hypertension Guidelines. Blood pressure measurement - is it good enough for accurate diagnosis of hypertension? Time might be in, for a paradigm shift (I).

Authors:  Cornel Pater
Journal:  Curr Control Trials Cardiovasc Med       Date:  2005-04-06

5.  Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry.

Authors:  Roland E Schmieder; Anselm K Gitt; Cornelia Koch; Peter Bramlage; Taoufik Ouarrak; Diethelm Tschöpe
Journal:  BMC Endocr Disord       Date:  2015-05-02       Impact factor: 2.763

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.